novel
strain
influenza
viru
emerg
caus
worldwid
pandem
sever
studi
suggest
viru
antigen
close
relat
human
influenza
virus
circul
prior
virus
recent
season
influenza
varieti
extent
individu
viru
carri
crossreact
cell
known
certain
degre
reactiv
would
expect
sinc
substanti
conserv
among
intern
protein
viru
present
studi
examin
product
multipl
cytokin
respons
viru
cell
healthi
adult
subject
year
age
born
post
evid
exposur
viru
blood
collect
prior
emerg
pandem
april
human
peripher
blood
mononuclear
cell
pbmc
stimul
vitro
panel
live
virus
assay
intracellular
cytokin
stain
flow
cytometri
although
result
variabl
subject
exhibit
cytokin
posit
cell
respons
cytokin
produc
cell
predominantli
singl
posit
triplecytokin
produc
cell
rel
rare
result
suggest
although
mani
adult
carri
crossreact
cell
emerg
pandem
viru
cell
function
limit
state
possibl
subject
recent
exposur
either
season
pandem
influenza
strain
sinc
april
pandem
caus
million
infect
worldwid
led
hospit
period
wwwcdcgovfluweeklyarch
hospit
case
report
patient
requir
intens
care
unitadmitt
estim
mortal
rate
intens
care
unitadmit
patient
viru
attack
rate
substanti
higher
season
flu
base
morbid
mortal
estim
mortal
rate
consid
hospit
nonhospit
similar
season
influenza
pattern
suscept
morbid
seen
infect
observ
earli
pandem
suggest
subject
previous
expos
antigen
similar
influenza
strain
vaccin
immun
hancock
et
al
measur
crossprotect
antibodi
titer
subject
found
titer
subject
born
prior
contrast
fewer
born
protect
antibodi
titer
reflect
greater
suscept
infect
although
young
subject
suscept
addit
factor
thought
contribut
diseas
attenu
popul
epidemiolog
studi
clearli
indic
antiinfluenza
serum
antibodi
level
provid
import
crossprotect
similar
influenza
viru
clade
prevent
secondari
influenza
infect
ident
viru
human
natur
librari
highli
specif
protect
antibodi
form
respons
natur
infect
vaccin
pandem
influenza
outbreak
occur
genet
shift
viru
lead
chang
hemagglutinin
ha
neuraminidas
na
viru
surfac
condit
patient
poor
crossprotect
antiinfluenza
antibodi
rapid
respons
immun
system
may
depend
conserv
viral
cell
epitop
recogn
crossreact
cell
major
known
influenza
epitop
recogn
class
mhc
complex
cell
deriv
intern
viru
protein
case
amino
acid
conserv
intern
protein
compar
season
influenza
amino
acid
conserv
ha
na
robust
circul
memori
cell
respons
expect
occur
prior
antigen
exposur
pandem
provid
excel
opportun
studi
role
memori
cell
healthi
adult
crossreact
strain
influenza
essenti
novel
individu
term
serum
neutral
antibodi
furthermor
vital
assess
crossreact
also
function
capac
circul
cell
subject
infect
influenza
within
last
three
year
might
expect
harbor
cell
quiescent
exhibit
limit
array
cytokin
initi
reactiv
vitro
base
high
degre
intern
epitop
conserv
compar
season
influenza
hypothes
subject
presum
would
nonetheless
measur
cell
respons
result
previou
prime
season
influenza
strain
furthermor
hypothes
qualiti
cell
antigenspecif
cytokin
respons
subject
recent
infect
influenza
would
exhibit
multiplecytokin
secret
polyfunct
cell
test
hypothes
chose
experiment
approach
util
whole
viru
vitro
stimul
peripher
blood
mononuclear
cell
pbmc
drawn
seroneg
subject
collect
prior
emerg
result
show
evid
exist
cell
immun
character
predominantli
singl
dual
cytokin
produc
cell
normal
healthi
donor
unit
bag
blood
collect
new
york
influenza
center
excel
nyic
vaccin
research
unit
octob
octob
tabl
approv
human
sampl
collect
obtain
univers
rochest
institut
review
board
donor
consent
sampl
donat
brief
questionnair
procedur
consist
nyic
healthi
donor
protocol
pbmc
isol
ficollpaqu
densiti
gradient
centrifug
cryopreserv
liquid
nitrogen
nyic
sampl
process
core
pbmc
thaw
warm
complet
media
rpmi
fb
penicillinstreptomycin
lglutamin
mediatech
manassu
rest
overnight
sixwel
polystyren
plate
costar
corn
ny
prepar
vitro
stimul
assay
perform
without
knowledg
subject
age
antibodi
titer
result
standard
hemagglutin
inhibit
assay
hai
perform
subject
plasma
serum
store
procedur
consist
previous
publish
method
briefli
serial
twofold
dilut
previous
frozen
serum
plasma
assay
abil
inhibit
agglutin
chicken
red
blood
cell
presenc
influenza
viru
viru
prepar
consist
allanto
fluid
infect
embryon
chicken
egg
collect
store
aliquot
c
season
anew
preval
human
strain
egg
grown
stock
deriv
lab
pandem
seed
virus
obtain
nih
biodefens
emerg
infect
resourc
beir
control
viru
laboratori
strain
reassort
season
surfac
ha
na
protein
deriv
aaichihong
intern
protein
apuerto
viral
core
use
vaccin
prepar
viru
titer
measur
three
techniqu
eid
egg
infecti
dose
plaqu
form
unit
pfu
mdck
cell
tcid
tissu
cultur
infecti
dose
mdck
cell
result
list
tabl
elispot
plate
millipor
multiscreen
ht
billerica
coat
monoclon
antibodi
mabtech
mariemont
oh
wash
block
complet
media
pbmc
rest
overnight
complet
media
cell
count
trypan
blue
exclus
plate
use
fresh
complet
media
serial
dilut
start
cellswel
pbmc
inocul
multipl
infect
moi
either
anew
caledonia
acalifornia
background
measur
cultur
contain
either
media
alon
allanto
fluid
mockinfect
egg
gestat
age
infect
egg
phytohemagglutinin
pha
use
posit
control
treat
cell
incub
overnight
wash
develop
use
biotinyl
secondari
monoclon
antibodi
mabtech
streptavidinalkalin
phosphatas
alkalin
phosphatas
substrat
kit
vector
laboratori
burlingam
ca
data
collect
use
autom
ctl
elispot
reader
cellular
technolog
ltd
shaker
height
oh
pbmc
thaw
describ
overnight
rest
cell
transfer
vbottom
tissuecultur
plate
costar
corn
ny
fresh
complet
media
final
concentr
well
inocul
staphylococc
enterotoxinb
seb
posit
control
final
concentr
sigma
aldrich
st
loui
mo
complet
media
alon
allanto
fluid
whole
viru
moi
infecti
unit
per
pbmc
place
c
humidifi
incub
moi
egggrown
viru
base
eid
allanto
fluid
volum
match
maximum
volum
viru
use
viral
stimul
condit
two
hour
incub
brefeldin
bd
bioscienc
san
diego
ca
ad
inhibit
cytokin
releas
golgi
blockad
hour
total
incub
two
without
eight
brefeldin
cell
refriger
overnight
c
follow
morn
cell
prepar
flow
cytometri
use
modifi
publish
protocol
immunocytochemistri
perform
fluoresc
tag
antibodi
chosen
gener
cell
phenotyp
analysi
cytokineproduc
cell
tabl
pbmc
wash
twice
buffer
mous
serum
ad
fcblock
pbmc
wash
resuspend
intracellularstain
cocktail
bd
pharmingen
biolegend
invitrogen
antibodi
one
hour
c
dark
pbmc
wash
buffer
resuspend
paraformaldehyd
solut
sampl
run
lsrii
cytomet
bd
fac
diva
softwar
analyz
use
flowjo
data
analysi
softwar
tree
star
inc
ashland
clinic
research
inventori
control
data
store
nyic
flurdm
influenza
research
data
manag
system
retriev
flurdm
univers
rochest
medic
center
depart
biostatist
comput
biolog
perform
statist
analys
data
analyz
sa
softwar
sa
institut
inc
cari
nc
usa
graphpad
prism
version
maco
x
graphpad
softwar
san
diego
ca
due
small
sampl
size
pair
donor
result
neg
control
viral
stimul
condit
compar
use
twosid
wilcoxon
signedrank
test
pvalu
consid
statist
signific
power
calcul
test
found
statist
signific
use
sa
system
modul
unifypow
calcul
power
confirm
bootstrap
approach
r
version
resampl
taken
differ
pair
observ
replac
resampl
size
resampl
wilcoxon
signedrank
test
use
test
hypothesi
mean
differ
power
estim
percentag
reject
null
hypothesi
among
test
subject
sampl
collect
nyic
healthi
donor
octob
august
subject
age
rang
year
sinc
pandem
influenza
activ
becom
local
widespread
juli
sampl
collect
octob
march
presum
viru
subject
report
vaccin
influenzalik
ill
season
subset
sampl
collect
april
august
test
hemagglutin
inhibit
assay
hai
specif
activ
titer
found
protect
level
tabl
initi
experi
use
elispot
assay
screen
subject
reactiv
season
laboratori
influenza
viru
strain
cryopreserv
pbmc
nine
subject
thaw
place
plate
nitrocellulos
membran
coat
captur
antibodi
cell
cultur
overnight
mockinfect
allanto
fluid
allanto
fluid
egg
infect
either
moi
eid
cell
plate
wash
develop
biotinyl
secondari
antibodi
streptavidin
alkalin
phosphatas
substrat
substanti
number
spot
form
cell
sfc
viru
influenza
detect
subject
though
one
subject
lowrespond
number
spotform
cell
sfc
significantli
differ
among
virus
test
data
suggest
healthi
adult
carri
substanti
number
crossreact
cell
recogn
newli
emerg
pandem
strain
find
consist
first
hypothesi
adult
without
confirm
exposur
viru
gener
respons
elispot
assay
distinguish
cell
type
make
cytokin
case
order
distinguish
cell
cell
type
develop
flow
cytometr
approach
use
intracellular
cytokin
cell
surfac
stain
brief
vitro
stimul
viru
panel
stain
develop
use
bd
lsrii
cytomet
describ
tabl
gate
strategi
depict
figur
doublet
dead
cell
exclud
draw
lymphocyt
gate
monocyt
b
cell
nk
nkt
cell
also
exclud
cell
select
analyz
ratio
infecti
viru
cell
number
multipl
infect
moi
optim
incub
human
pbmc
donor
differ
amount
viru
rang
eid
per
pbmc
follow
stain
intracellular
cytokin
cell
surfac
marker
describ
maxim
cytokin
product
minimum
cell
death
observ
moi
rang
eid
per
cell
virus
test
result
repres
subject
whose
pbmc
stimul
egggrown
viru
shown
figur
first
interest
quantifi
lymphocyt
respons
secret
pbmc
stimul
prior
ad
brefeldin
prevent
cytokin
secret
presenc
drug
cell
process
flow
cytometri
cultur
contain
media
alon
allanto
fluid
use
neg
control
seb
posit
control
use
set
boundari
cytokin
posit
cell
major
subject
cell
compris
major
lymphocyt
figur
subject
higher
proport
nk
cell
produc
cytokin
frequenc
cytokin
posit
cell
low
variabl
demonstr
notabl
pattern
gener
frequenc
hierarchi
nk
season
nk
pandem
subject
similar
rise
cell
compar
cell
substanti
nk
cell
respons
subject
reinforc
limit
elispot
understand
vitro
pbmc
cytokin
respons
multipl
cell
popul
present
next
examin
cell
respons
frequenc
virusspecif
cell
quantifi
cell
posit
one
cytokin
frequenc
cytokin
posit
cell
variabl
subject
subject
howev
case
proport
cell
observ
allanto
fluid
media
control
well
season
laboratori
virus
though
frequenc
slightli
lower
figur
presenc
viru
proport
cell
usual
higher
either
cell
contrast
cell
frequenc
cell
frequenc
similar
neg
control
nonsignific
find
limit
small
sampl
size
rais
risk
accept
null
hypothesi
valu
subject
averag
frequenc
significantli
higher
presenc
compar
control
figur
result
demonstr
healthi
adult
carri
circul
influenza
virusspecif
crossreact
cell
peripher
blood
reinforc
conclus
drawn
elispot
assay
cell
secret
one
three
cytokin
test
associ
better
prognosi
number
chronic
viru
infect
compar
singl
cytokineposit
cell
presum
polyfunct
cell
effect
control
viru
replic
postul
higher
state
activ
andor
recent
stimul
antigen
whether
cell
offer
advantag
influenza
unknown
assess
function
statu
flu
specif
cell
subject
without
evid
recent
infect
determin
proport
singl
doubl
tripl
cytokin
produc
cell
singl
cytokin
posit
cell
crosscompar
use
boolean
analysi
strategi
two
cytokin
figur
respons
highest
frequenc
crossreact
cell
seen
singlecytokin
produc
preval
figur
b
statist
nonsignific
singl
cell
influenc
small
sampl
size
rais
risk
type
ii
error
cell
make
two
cytokin
follow
next
frequent
doubl
cytokin
profil
observ
subject
regardless
viru
use
stimul
cell
figur
b
subject
popul
secret
cell
could
detect
low
frequenc
cell
rare
among
subject
low
proport
detect
tripl
cytokin
produc
cell
viru
strain
rel
rare
although
low
frequenc
polyfunct
cell
signific
p
increas
cell
make
two
cytokin
allanto
fluid
background
stimul
trend
toward
greater
rise
seen
season
influenza
strain
figur
determin
activ
cell
phenotyp
measur
cytokin
product
per
cell
basi
use
mean
fluoresc
intens
mfi
tripl
doubl
singl
cytokin
produc
cell
bulk
popul
stimul
condit
includ
neg
control
highest
mfi
seen
tripleand
dual
produc
tripleproduc
mfi
similar
neg
control
wherea
greater
compar
neg
control
dual
produc
mfi
valu
significantli
greater
neg
control
p
lowest
mfi
seen
singl
cytokin
produc
stimul
condit
shown
mfi
vari
significantli
base
cytokin
profil
thu
product
divers
cytokin
product
correl
amount
produc
per
cell
find
consist
supposit
multipl
cytokin
product
associ
higher
function
capac
set
test
predict
adult
known
expos
influenza
viru
would
memori
cell
crossreact
novel
strain
well
recent
prototyp
influenza
strain
result
support
hypothesi
cell
previous
prime
multipl
strain
season
influenza
viru
activ
stimul
pandem
influenza
viru
singl
cytokin
produc
cell
far
predomin
type
cell
observ
regardless
viru
use
stimul
cell
given
individu
pattern
cytokin
respons
similar
among
virus
test
suggest
novel
pandem
strain
unusu
type
immun
respons
elicit
frequent
observ
cytokin
follow
singl
posit
cell
detect
neg
control
low
frequenc
cell
peripheri
may
indic
predomin
effector
phenotyp
cell
memori
phenotyp
subject
function
heterogen
viru
specif
cell
emphas
observ
cell
produc
two
cytokin
cell
produc
highest
preval
follow
produc
although
singl
produc
cell
significantli
frequent
among
cell
stimul
viru
control
posit
cell
coupl
alon
virusspecif
popul
could
discern
background
level
find
recent
report
makedona
et
al
observ
neg
correl
perforin
upregul
secret
would
suggest
polyfunction
associ
might
distinguish
memori
effector
phenotyp
result
context
publish
find
suggest
cell
respond
may
repres
popul
pois
prolifer
respons
brief
antigenstimul
prior
exert
addit
antivir
effector
function
cell
also
associ
better
memori
cell
format
howev
signific
produc
popul
cell
studi
known
find
expand
popul
influenzaspecif
polyfunct
crossreact
memori
cell
subject
without
recent
exposur
influenza
viru
vaccin
novel
polyfunct
cell
report
associ
diseas
control
set
chronic
infect
hiv
hepat
c
also
postul
polyfunct
cell
repres
highli
activ
less
exhaust
phenotyp
may
effect
control
infect
singlecytokineproduc
cell
less
evid
role
polyfunct
cell
acut
infect
report
find
increas
mfi
associ
cell
suggest
may
distinct
popul
highli
activ
cell
capabl
prolifer
secret
cytokin
acut
infect
perhap
exert
cytolyt
function
use
mean
fluoresc
intens
compar
rel
size
cytokin
output
per
cell
valid
use
studi
cell
autoimmun
chronic
diseas
examin
influenzaspecif
cell
method
may
use
approach
compar
rel
activ
vitro
cell
assay
evalu
cytotox
function
polyfunct
cell
may
also
aid
better
defin
role
cell
popul
crossprotect
adapt
immun
import
antigen
dissimilar
influenza
virus
shown
anim
studi
limit
human
studi
strong
evid
literatur
cell
play
larg
role
provid
crossimmun
influenza
viru
drift
enough
evad
neutral
antibodi
jameson
et
al
show
human
cytotox
cell
specif
season
influenza
epitop
show
crossreact
avian
swineorigin
strain
degre
cytotox
heterosubtyp
challeng
similar
homosubtyp
challeng
larg
depend
hlatyp
conserv
amino
acid
sequenc
within
known
cell
epitop
clinic
relev
cell
function
partial
explor
two
recent
public
shahid
et
al
show
low
granzym
b
activ
low
ratio
preill
correl
suscept
influenza
correl
first
demonstr
mcelhaney
et
al
measur
serum
antibodi
titer
pbmc
granzym
cytokin
respons
elderli
subject
immun
inactiv
influenza
vaccin
found
popul
higher
ratio
correl
protect
wherea
antibodi
level
recent
public
group
show
neg
correl
granzym
b
activ
influenza
infect
import
cell
also
support
experi
anim
model
show
cellmedi
protect
heterosubtyp
influenza
infect
absenc
b
cell
immun
regard
viru
recent
studi
demonstr
substanti
cell
mediat
protect
lethal
infect
anim
prime
laboratori
recent
season
human
influenza
virus
evid
serolog
protect
even
sera
deriv
prime
donor
serum
fulli
protect
studi
highlight
import
studi
qualiti
simpli
frequenc
cell
immun
predict
popul
suscept
diseas
phenomenon
consist
viru
behavior
human
would
potenti
explan
diseas
attenu
set
high
suscept
studi
requir
demonstr
clinic
benefit
associ
polyfunct
cell
though
demonstr
could
serv
novel
immun
correl
result
studi
util
whole
viru
vitro
stimul
consist
find
sever
group
investig
preexist
immun
human
greenbaum
et
al
demonstr
detect
secret
memori
phenotyp
cell
respons
peptid
pool
conserv
epitop
tu
et
al
found
popul
cell
cytotox
activ
expans
antigenspecif
secret
cell
subject
recent
vaccin
season
influenza
though
frequenc
antigenspecif
cell
lower
stimul
season
influenza
result
still
statist
signific
studi
focus
analysi
crossprotect
cell
respons
assay
develop
reveal
sever
import
factor
enabl
use
whole
viru
vitro
stimul
includ
use
allanto
fluid
neg
control
util
egggrown
viral
stock
use
multipl
viral
prepar
account
variabl
cell
respons
felt
import
understand
cell
respons
whole
viru
sinc
cell
presum
react
process
viru
within
infect
antigen
present
cell
use
whole
viru
close
simul
natur
infect
antigen
present
unfortun
approach
introduc
question
similar
individu
lab
viral
strain
circul
influenza
strain
whether
small
differ
lab
strain
account
differ
result
although
found
signific
increas
cytokineproduc
cell
respons
compar
neg
control
consist
trend
toward
lower
frequenc
compar
season
laboratori
influenzaspecif
respons
possibl
chang
surfac
protein
influenza
chang
signal
receiv
cell
therebi
chang
either
prolifer
cytokin
profil
time
howev
whether
differ
influenza
strain
result
lower
frequenc
precursor
cell
specif
intrins
viru
strain
clear
effect
egg
tissu
cultur
passag
human
influenza
virus
human
lymphocyt
infect
antigenpresent
exhaust
investig
investig
could
shed
light
issu
interestingli
anim
studi
acalifornia
stock
use
studi
show
high
degre
virul
similar
laboratori
strain
consist
view
viru
fit
replic
cell
highli
permiss
egg
mdck
cell
line
nevertheless
possibl
variabl
ha
protein
introduc
pandem
strain
affect
viru
abil
infect
pbmc
would
explain
lower
cell
respons
also
retain
abil
caus
diseas
respiratori
tract
overal
observ
measur
low
frequenc
crossreact
influenzaspecif
cell
circul
subject
recent
infect
major
circul
memori
cell
specif
influenza
quiescent
state
restrict
function
find
rare
polyfunct
cytokin
produc
cell
suggest
protect
diseas
cell
may
quit
limit
find
polyfunct
cell
may
partli
explain
signific
number
healthi
young
middleag
adult
exhibit
sign
infect
pandem
base
seropreval
exposur
studi
carrat
et
al
estim
asymptomat
influenza
infect
may
occur
around
expos
individu
though
exposur
rate
difficult
accur
determin
therefor
possibl
either
infrequ
exposur
recurr
asymptomat
season
influenza
infect
may
lead
termin
differenti
effector
cell
popul
shown
model
either
chronic
activ
latent
infect
frequent
repeat
antigen
exposur
associ
termin
differenti
phenotyp
less
like
prolifer
cognat
antigen
engag
interest
see
frequenc
polyfunct
cell
increas
subject
recov
document
infect
altern
well
establish
optim
immun
protect
heterosubtyp
infect
provid
memori
cell
locat
respiratori
tissu
present
analysi
specif
investig
home
potenti
cell
draw
conclus
relationship
cytokin
product
home
show
evid
preexist
cell
immun
howev
known
epitop
cell
respond
immun
model
predict
like
presenc
preexist
immun
base
high
percent
conserv
mhc
class
epitop
found
bioinformat
resourc
would
seem
logic
memori
cell
cell
respond
epitop
highli
conserv
among
differ
influenza
virus
verif
cell
observ
react
conserv
sequenc
requir
care
map
class
hla
restrict
epitop
also
possibl
small
nucleotid
chang
among
virus
lead
alter
recognit
differ
individu
base
hla
type
resolut
unansw
question
critic
target
cell
vaccin
design
studi
rais
question
effect
cytotox
cell
immun
control
pandem
howev
sinc
subject
studi
fall
demograph
high
suscept
studi
found
evid
exist
cell
immun
pandem
strain
influenza
viru
presum
subject
character
predominantli
singlecytokin
produc
dual
cell
low
frequenc
triplecytokin
secret
cell
activ
popul
found
associ
product
measur
mean
fluoresc
intens
crossreact
cell
may
contribut
diseas
attenu
highli
suscept
popul
recent
pandem
